PGJ2 restores RA sensitivity in melanoma cells by decreasing PRAME and EZH2

J Dermatol Sci. 2014 Mar;73(3):258-61. doi: 10.1016/j.jdermsci.2013.11.003. Epub 2013 Nov 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / analysis
  • Antigens, Neoplasm / physiology*
  • Cell Line, Tumor
  • Enhancer of Zeste Homolog 2 Protein
  • Humans
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Polycomb Repressive Complex 2 / analysis
  • Polycomb Repressive Complex 2 / physiology*
  • Prostaglandin D2 / analogs & derivatives*
  • Prostaglandin D2 / pharmacology
  • Tretinoin / pharmacology*

Substances

  • Antigens, Neoplasm
  • PRAME protein, human
  • Tretinoin
  • 9-deoxy-delta-9-prostaglandin D2
  • EZH2 protein, human
  • Enhancer of Zeste Homolog 2 Protein
  • Polycomb Repressive Complex 2
  • Prostaglandin D2